These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18583618)

  • 1. Multiple molecular forms of circulating cardiac troponin: analytical and clinical significance.
    Gaze DC; Collinson PO
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):349-55. PubMed ID: 18583618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and biochemical heterogeneity of cardiac troponins: clinical and laboratory implications.
    Lippi G; Targher G; Franchini M; Plebani M
    Clin Chem Lab Med; 2009; 47(10):1183-94. PubMed ID: 19754353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac troponins and renal disease.
    De Zoysa JR
    Nephrology (Carlton); 2004 Apr; 9(2):83-8. PubMed ID: 15056267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac troponins and high-sensitivity cardiac troponin assays.
    Conrad MJ; Jarolim P
    Clin Lab Med; 2014 Mar; 34(1):59-73, vi. PubMed ID: 24507787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prescription, assay and interpretation of cardiac troponins tests: guidelines from SFBC-CNBC troponin working group].
    Capolaghi B; Charbonnier B; Dumontet M; Hennache B; Henninot J; Laperche T; Lavoinne A; Lefèvre G; Morin C; Pateron D;
    Ann Biol Clin (Paris); 2005; 63(3):245-61. PubMed ID: 15951257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of cardiac troponin C function by the cardiac-specific N-terminus of troponin I: influence of PKA phosphorylation and involvement in cardiomyopathies.
    Baryshnikova OK; Li MX; Sykes BD
    J Mol Biol; 2008 Jan; 375(3):735-51. PubMed ID: 18042489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood cardiac troponin in toxic myocardial injury: archetype of a translational safety biomarker.
    O'Brien PJ
    Expert Rev Mol Diagn; 2006 Sep; 6(5):685-702. PubMed ID: 17009904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial.
    Wilson SR; Sabatine MS; Braunwald E; Sloan S; Murphy SA; Morrow DA
    Am Heart J; 2009 Sep; 158(3):386-91. PubMed ID: 19699861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent assay developments for cardiac troponins: are we sensitive enough to recognize the high sensitives?].
    Schulz O; Schimke I
    Herz; 2008 Nov; 33(7):526-31. PubMed ID: 19066749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of cardiac troponins.
    Collinson PO; Boa FG; Gaze DC
    Ann Clin Biochem; 2001 Sep; 38(Pt 5):423-49. PubMed ID: 11587122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia.
    Venge P; Johnston N; Lindahl B; James S
    J Am Coll Cardiol; 2009 Sep; 54(13):1165-72. PubMed ID: 19761938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use and misuse of cardiac troponins in clinical practice.
    Gupta S; de Lemos JA
    Prog Cardiovasc Dis; 2007; 50(2):151-65. PubMed ID: 17765476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A translational approach to detecting drug-induced cardiac injury with cardiac troponins: consensus and recommendations from the Cardiac Troponins Biomarker Working Group of the Health and Environmental Sciences Institute.
    Berridge BR; Pettit S; Walker DB; Jaffe AS; Schultze AE; Herman E; Reagan WJ; Lipshultz SE; Apple FS; York MJ
    Am Heart J; 2009 Jul; 158(1):21-9. PubMed ID: 19540388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodialysis patients longitudinally assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and cardiac troponin I assays.
    Jacobs LH; van de Kerkhof J; Mingels AM; Kleijnen VW; van der Sande FM; Wodzig WK; Kooman JP; van Dieijen-Visser MP
    Ann Clin Biochem; 2009 Jul; 46(Pt 4):283-90. PubMed ID: 19454537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the usefulness of biomarkers for cardiac and skeletal myotoxicity in rats.
    Tonomura Y; Mori Y; Torii M; Uehara T
    Toxicology; 2009 Dec; 266(1-3):48-54. PubMed ID: 19854236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relevance of the detection of troponins to the forensic diagnosis of cardiac contusion.
    Peter J; Kirchner A; Kuhlisch E; Menschikowski M; Neef B; Dressler J
    Forensic Sci Int; 2006 Jul; 160(2-3):127-33. PubMed ID: 16269219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dilated cardiomyopathy G159D mutation in cardiac troponin C weakens the anchoring interaction with troponin I.
    Baryshnikova OK; Robertson IM; Mercier P; Sykes BD
    Biochemistry; 2008 Oct; 47(41):10950-60. PubMed ID: 18803402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac troponins and left ventricular hypertrophy in hemodialysis patients.
    Petrović D; Obrenović R; Stojimirović B
    Clin Lab; 2008; 54(5-6):145-52. PubMed ID: 18780659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of cardiac damage and changes in function after exercise.
    Whyte GP
    Med Sci Sports Exerc; 2008 Aug; 40(8):1416-23. PubMed ID: 18614951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with increased serum levels of specific markers of myocardial injury--cardiac troponins T and I in chronic haemodialysis patients.
    Sutidze M; Kajrishvili M; Tsimakuridze M; Khachapuridze N; Sulakvelidze M
    Georgian Med News; 2009 Apr; (169):39-43. PubMed ID: 19430042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.